8 biotechs that deserve more attention

07/9/2012 | Xconomy

Some biotech firms are developing promising treatments or generating big sales without attracting public attention, Luke Timmerman writes. "Despite all the ways a biotech company can capture public attention, there are lots of companies out there doing good things below the public radar," he writes. He lists advances and achievements by Pharmacyclics, Medivation, Ironwood Pharmaceuticals, Seattle Genetics, Alexion Pharmaceuticals, Cubist Pharmaceuticals, Halozyme Therapeutics and NewLink Genetics.

View Full Article in:

Xconomy

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC